drugset / Trial / NCT01203124
A Study to Investigate the Impact of Dose and Dosing Frequency of AZD8848 on the Response on Biomarkers
RandomizedParallel-groupSingle-blindBasic science
Summary
The study will investigate how the dose of AZD8848 and the dosing frequency will affect the immunological/inflammatory response by measuring the production of biomarkers in blood and nasal lavage.
Timeline
- Start
- 2010-11
- Primary completion
- 2011-03
- Completion
- 2012-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AZD8848 | Small molecule | — | Intranasal |
Indications
No indication recorded.